Table 3 Measurements of percentage 24 h mortality compared between WHO cone test and I-ACT by net brand and age
|  | 24 h geometric mean  % mortality (95% confidence interval) | Odds ratio | 95% confidence interval | p-value | |||
|---|---|---|---|---|---|---|---|
Year 1 | Year 2 | Year 3 | Overall | ||||
Olyset® | |||||||
 Cone test | 19.4 (17.9–20.9) | 7.2 (6.2–8.2) | 34.1 (32.1–36.2) | 20.2 (19.2–21.2) | 1 |  |  |
 I-ACT | 87.2 (84.1–90.3) | 68.9 (64.5–73.4) | 69.8 (65.4–74.3) | 75.1 (72.5–77.6) | 17.8 | 16.3–19.5 | < 0.0001 |
PermaNet® 2.0 | |||||||
 Cone test | 93.5 (92.4–94.7) | 85.3 (83.3–87.2) | 83.2 (81.4–85.1) | 87.4 (86.4–88.3) | 1 |  |  |
 I-ACT | 98.4 (97.7–99.1) | 91.5 (88.8–94.2) | 87.8 (84.2–91.5) | 92.5 (90.9–94.1) | 2.1 | 1.8–2.3 | < 0.0001 |
Netprotect® | |||||||
 Cone test | 93.1 (92.1–94.2) | 81.1 (78.9–83.3) | 82.2 (80.1–83.7) | 85.4 (84.4–86.4) | 1 |  |  |
 I-ACT | 99.1 (98.6–99.6) | 96 (94.4–97.6) | 89.1 (85.9–92.1) | 94.6 (93.4–95.9) | 3.6 | 3.2–4.1 | < 0.0001 |
Overall | |||||||
 Cone test | 68.2 (66.6–69.8) | 58 (56.2–59.8) | 66.5 (65.1–67.9) | 64.2 (63.3–65.2) | 1 |  |  |
 I-ACT | 94.9 (93.7–96.2) | 85.5 (83.2–87.7) | 82.2 (79.8–84.5) | 87.4 (86.2–88.6) | 7.9 | 7.4–8.4 | < 0.0001 |